winter
month
variou
virus
may
caus
respiratori
ill
circul
wide
adult
popul
lead
diseas
burden
public
health
consider
concern
diagnosi
respiratori
infect
usual
base
clinic
epidemiolog
criteria
sever
case
confirm
pathogen
detect
henc
data
patient
admit
hospit
remain
limit
one
partial
except
influenza
viru
mangtani
et
al
elliot
et
al
schanzer
et
al
van
den
dool
et
al
ison
order
evalu
cost
benefit
molecular
diagnosi
need
better
definit
preval
common
respiratori
virus
gilca
et
al
recent
year
use
molecular
techniqu
human
rhinoviru
hrv
recogn
common
caus
hospit
admiss
agent
bronchopneumonia
exacerb
chronic
pulmonari
condit
elderli
puro
et
al
mcmanu
et
al
howev
studi
conduct
adult
patient
attend
emerg
depart
estim
burden
respiratori
infect
hrv
compar
respiratori
virus
previou
studi
pierang
et
al
show
triag
criteria
base
case
definit
ill
lead
identif
patient
infect
influenza
viru
also
includ
patient
lack
diagnos
respiratori
infect
present
emerg
depart
could
imped
prevent
viru
spread
appropri
case
manag
within
framework
respiratori
infect
surveil
project
emerg
depart
policlinico
umberto
hospit
sapienza
univers
rome
result
studi
februari
march
februari
march
present
test
major
respiratori
virus
includ
hrv
undertaken
patient
present
feverpreced
fever
respiratori
symptom
result
virolog
clinic
character
respiratori
ill
emerg
depart
led
new
insight
character
clinic
manifest
compar
respiratori
condit
consecut
patient
met
inclus
criteria
enrol
studi
februari
march
februari
march
attend
policlinico
umberto
hospit
emerg
depart
one
largest
emerg
depart
rome
approxim
consult
per
month
condit
inclus
criteria
present
fever
admiss
preced
day
one
follow
diagnos
triag
accord
intern
classif
diseas
revis
code
pharyng
acut
bronchiti
acut
bronchopneumonia
organ
otherwis
specifi
pneumonia
code
dyspnea
respiratori
distress
cough
thorac
pain
abnorm
find
diagnost
imag
lung
influenza
influenza
pneumonia
influenza
respiratori
manifest
inform
consent
clinic
data
obtain
total
patient
patient
februarymarch
men
women
median
age
year
age
rang
year
februarymarch
men
women
median
age
year
age
rang
year
studi
approv
hospit
ethic
committe
inform
consent
sought
particip
patient
medic
examin
patient
either
refer
gener
practition
admit
differ
depart
hospit
emerg
medicin
infecti
diseas
intern
medicin
depart
nasopharyng
wash
collect
patient
within
hr
first
contact
deliv
ice
virolog
laboratori
within
hr
collect
rna
extract
undertaken
use
qiaamp
viral
rna
mini
kit
qiagen
spa
milan
itali
remaind
frozen
extract
rna
subject
revers
transcript
random
hexam
cdna
ad
polymeras
chain
reaction
pcr
detect
main
respiratori
virus
particular
pcr
amplifi
untransl
hrv
deffernez
et
al
multiplex
pcr
target
genom
segment
influenza
b
grondahl
et
al
pcr
amplifi
conserv
subunit
respiratori
syncyti
viru
rsv
b
grondahl
et
al
pcr
target
l
gene
human
metapneumoviru
hmpv
van
den
hoogen
et
al
specif
nest
pcr
undertaken
describ
previous
parainfluenzavirus
pierang
et
al
amplif
product
run
agaros
gel
molecular
weight
marker
identif
posit
sampl
confirm
test
second
aliquot
test
use
compar
patient
data
accord
viru
result
signific
fix
level
analysi
perform
use
spss
total
nasopharyng
wash
collect
prospect
enrol
patient
februarymarch
sampl
viru
posit
wherea
februarymarch
viru
posit
rate
significantli
lower
p
calcul
use
test
rhinovirus
detect
sampl
one
also
posit
influenza
therefor
includ
viru
group
tabl
ii
pcr
result
posit
influenza
obtain
sampl
patient
enrol
first
studi
period
posit
result
occur
sampl
collect
februari
influenza
b
detect
sampl
nasopharyng
wash
test
posit
virus
includ
one
sampl
posit
rsv
three
two
sampl
posit
hmpv
patient
age
sign
symptom
emerg
depart
present
stratifi
viru
result
shown
tabl
patient
significantli
younger
signific
differ
found
patient
sign
symptom
present
patient
infect
virus
hrv
present
less
frequent
fever
frequent
preced
fever
dyspnoea
triag
compar
patient
viru
detect
tabl
patient
white
blood
cell
wbc
count
abnorm
chest
result
presenc
lung
consolid
indic
pneumonia
previou
chronic
condit
diagnosi
emerg
depart
medic
examin
subsequ
hospit
shown
tabl
ii
distribut
two
age
year
older
viru
hrv
viru
viru
detect
signific
differ
found
age
infect
group
tabl
ii
number
patient
present
leucocytosi
defin
wbc
abnorm
chest
consolid
observ
significantli
often
elderli
patient
viru
detect
group
expect
health
condit
frequent
patient
year
old
signific
differ
observ
patient
group
tabl
ii
diagnos
ill
upper
respiratori
tract
infect
lower
respiratori
tract
infect
dyspnoeachron
obstruct
pulmonari
diseas
diagnos
frequent
patient
group
tabl
ii
patient
year
wherea
younger
patient
receiv
frequent
diagnosi
ill
patient
year
admit
hospit
significantli
higher
rate
younger
one
signific
differ
observ
viru
group
term
subsequ
hospit
tabl
ii
last
two
winter
februari
march
consecut
patient
seek
care
respiratori
symptom
larg
emerg
depart
rome
examin
molecular
test
common
respiratori
virus
undertaken
rate
studi
period
respect
differ
significantli
influenza
sampl
februarymarch
due
pandem
influenza
viru
circul
occur
earlier
usual
octobernovemb
epidem
influenza
howev
statist
differ
incid
case
total
nasopharyng
wash
collect
case
respect
hrv
notic
rate
consist
rate
infect
report
previous
sever
author
monto
et
al
minoss
et
al
lieberman
et
al
respiratori
virus
rsv
hmpv
detect
case
influenza
b
parainfluenzavirus
found
adenovirus
coronavirus
bocaviru
test
howev
given
low
rate
found
consid
sampl
singl
viru
infect
triag
patient
hrv
present
frequent
patient
cough
symptom
ill
tendenc
present
fever
fewer
preced
fever
symptom
patient
respiratori
virus
patient
age
year
hrv
appear
primari
caus
ill
inde
diagnos
either
mild
respiratori
ill
result
lowest
rate
hospit
admit
hospit
condit
convers
patient
year
hrv
diagnos
sever
respiratori
condit
led
high
rate
hospit
similar
respiratori
viru
infect
patient
year
present
abnorm
chest
consolid
statist
less
frequent
elderli
patient
suffer
bacteri
pneumonia
howev
abnorm
chest
result
patient
differ
significantli
patient
overal
patient
age
year
age
hrv
respiratori
viru
infect
contribut
half
diagnos
dyspnoea
chronic
obstruct
pulmonari
diseas
acut
exacerb
notabl
hrv
frequent
singl
agent
detect
diagnos
report
previou
paper
mcmanu
et
al
kherad
et
al
recommend
hrv
includ
virolog
diagnosi
sever
respiratori
infect
gambarino
et
al
lieberman
et
al
recent
develop
commerci
multiplex
pcr
panel
respiratori
virus
includ
hrv
inclus
hrv
virolog
diagnost
respiratori
specimen
may
greatli
increas
viru
detect
frequenc
acut
chronic
respiratori
tract
diseas
without
real
clinic
signific
inde
posit
pcr
hrv
necessarili
indic
associ
overt
diseas
especi
younger
adult
evid
group
howev
potenti
hrv
diffus
frail
patient
consid
emerg
depart
import
site
pathogen
transmiss
virolog
diagnosi
could
effect
prevent
transmiss
respiratori
agent
among
patient
appropri
case
manag
emerg
depart
often
first
point
call
peopl
seek
medic
care
syndrom
surveil
implement
itali
mani
countri
report
real
time
admiss
peak
could
lead
earli
detect
infecti
diseas
outbreak
et
al
ansaldi
et
al
may
et
al
convers
complet
virolog
diagnosi
monitor
outbreak
would
impli
time
delay
report
studi
hrv
infect
may
resembl
clinic
ill
monto
et
al
pierang
et
al
hrv
case
might
well
confound
syndrom
surveil
hrv
common
viru
detect
sampl
collect
recent
pandem
viru
test
follin
et
al
addit
nation
surveil
influenza
sweden
franc
result
alert
pandem
influenza
circul
earli
week
septemb
due
increas
incid
ill
increas
actual
due
hrv
infect
lind
et
al
casalegno
et
al
thu
virolog
diagnosi
emerg
depart
may
price
worth
pay
addit
inform
infect
agent
monitor
infecti
diseas
outbreak
overal
result
studi
show
hrv
major
viral
infect
adult
seek
medic
care
respiratori
condit
emerg
depart
present
obviou
distinguish
clinic
featur
caus
respiratori
distress
lower
respiratori
tract
ill
older
patient
virolog
diagnosi
respiratori
infect
whenev
need
includ
molecular
test
hrv
viru
signific
healthcar
impact
associ
frequent
admiss
hospit
elderli
